Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385555322> ?p ?o ?g. }
Showing items 1 to 99 of
99
with 100 items per page.
- W4385555322 endingPage "2023" @default.
- W4385555322 startingPage "00037" @default.
- W4385555322 abstract "Background The phase 3 QUEST ( NCT02414854 ) and TRAVERSE ( NCT02134028 ) studies demonstrated the efficacy of dupilumab 200/300 mg versus placebo every 2 weeks for 52 weeks (QUEST) and dupilumab 300 mg up to an additional 96 weeks (TRAVERSE) in patients ≥12 years of age with uncontrolled, moderate-to-severe asthma. Overall, safety was consistent with the known dupilumab safety profile. This post hoc analysis assessed long-term dupilumab efficacy for up to 3 years by exacerbation history. Patients and methods Unadjusted annualised severe exacerbation rates (AER) and change from parent study baseline (PSBL) in pre-bronchodilator forced expiratory volume in 1 s (FEV 1 ) and 5-item Asthma Control Questionnaire (ACQ-5) score were assessed in patients with PSBL eosinophils ≥150 cells·µL −1 or fractional exhaled nitric oxide ≥20 ppb and 1 (n=624), 2 (n=344), or ≥3 (n=311) exacerbations in the year before enrolment in QUEST. Results In all three groups, dupilumab treatment progressively reduced AER range to 0.17–0.30 during TRAVERSE (Weeks 48–96), increased pre-bronchodilator FEV 1 range by 0.28–0.49 L by Week 96 and improved asthma control (reduced ACQ-5 score range by 1.51–2.03 by Week 48). For patients who first received dupilumab upon TRAVERSE enrolment, AER decreased, and lung function and asthma control improved rapidly, as was observed upon initiation of dupilumab in QUEST. Dupilumab was efficacious regardless of exacerbation history. Conclusion For patients with uncontrolled, moderate-to-severe asthma with elevation of at least one type 2 biomarker, dupilumab treatment provides sustained, long-term reduction of exacerbation rates and improvements in lung function and asthma control irrespective of exacerbation history." @default.
- W4385555322 created "2023-08-04" @default.
- W4385555322 creator A5010309403 @default.
- W4385555322 creator A5017711682 @default.
- W4385555322 creator A5021417774 @default.
- W4385555322 creator A5024974445 @default.
- W4385555322 creator A5025719019 @default.
- W4385555322 creator A5029849168 @default.
- W4385555322 creator A5037227971 @default.
- W4385555322 creator A5038228413 @default.
- W4385555322 creator A5043657394 @default.
- W4385555322 creator A5059328493 @default.
- W4385555322 creator A5069220861 @default.
- W4385555322 creator A5082059107 @default.
- W4385555322 creator A5083847190 @default.
- W4385555322 date "2023-08-03" @default.
- W4385555322 modified "2023-10-18" @default.
- W4385555322 title "Impact of exacerbation history on long-term efficacy of dupilumab in patients with asthma" @default.
- W4385555322 cites W1996417170 @default.
- W4385555322 cites W2008743846 @default.
- W4385555322 cites W2015105473 @default.
- W4385555322 cites W2061435251 @default.
- W4385555322 cites W2084958270 @default.
- W4385555322 cites W2101401558 @default.
- W4385555322 cites W2105521580 @default.
- W4385555322 cites W2160302514 @default.
- W4385555322 cites W2162590783 @default.
- W4385555322 cites W2517035143 @default.
- W4385555322 cites W2594033175 @default.
- W4385555322 cites W2595571488 @default.
- W4385555322 cites W2803941918 @default.
- W4385555322 cites W2969244187 @default.
- W4385555322 cites W2996174934 @default.
- W4385555322 cites W3178469257 @default.
- W4385555322 cites W3206170968 @default.
- W4385555322 cites W4226321823 @default.
- W4385555322 doi "https://doi.org/10.1183/23120541.00037-2023" @default.
- W4385555322 hasPublicationYear "2023" @default.
- W4385555322 type Work @default.
- W4385555322 citedByCount "0" @default.
- W4385555322 crossrefType "journal-article" @default.
- W4385555322 hasAuthorship W4385555322A5010309403 @default.
- W4385555322 hasAuthorship W4385555322A5017711682 @default.
- W4385555322 hasAuthorship W4385555322A5021417774 @default.
- W4385555322 hasAuthorship W4385555322A5024974445 @default.
- W4385555322 hasAuthorship W4385555322A5025719019 @default.
- W4385555322 hasAuthorship W4385555322A5029849168 @default.
- W4385555322 hasAuthorship W4385555322A5037227971 @default.
- W4385555322 hasAuthorship W4385555322A5038228413 @default.
- W4385555322 hasAuthorship W4385555322A5043657394 @default.
- W4385555322 hasAuthorship W4385555322A5059328493 @default.
- W4385555322 hasAuthorship W4385555322A5069220861 @default.
- W4385555322 hasAuthorship W4385555322A5082059107 @default.
- W4385555322 hasAuthorship W4385555322A5083847190 @default.
- W4385555322 hasBestOaLocation W43855553221 @default.
- W4385555322 hasConcept C126322002 @default.
- W4385555322 hasConcept C142724271 @default.
- W4385555322 hasConcept C204787440 @default.
- W4385555322 hasConcept C27081682 @default.
- W4385555322 hasConcept C2776042228 @default.
- W4385555322 hasConcept C2777014857 @default.
- W4385555322 hasConcept C2779824493 @default.
- W4385555322 hasConcept C2780333948 @default.
- W4385555322 hasConcept C2781142857 @default.
- W4385555322 hasConcept C71924100 @default.
- W4385555322 hasConcept C90924648 @default.
- W4385555322 hasConceptScore W4385555322C126322002 @default.
- W4385555322 hasConceptScore W4385555322C142724271 @default.
- W4385555322 hasConceptScore W4385555322C204787440 @default.
- W4385555322 hasConceptScore W4385555322C27081682 @default.
- W4385555322 hasConceptScore W4385555322C2776042228 @default.
- W4385555322 hasConceptScore W4385555322C2777014857 @default.
- W4385555322 hasConceptScore W4385555322C2779824493 @default.
- W4385555322 hasConceptScore W4385555322C2780333948 @default.
- W4385555322 hasConceptScore W4385555322C2781142857 @default.
- W4385555322 hasConceptScore W4385555322C71924100 @default.
- W4385555322 hasConceptScore W4385555322C90924648 @default.
- W4385555322 hasFunder F4320307781 @default.
- W4385555322 hasFunder F4320311600 @default.
- W4385555322 hasIssue "5" @default.
- W4385555322 hasLocation W43855553221 @default.
- W4385555322 hasOpenAccess W4385555322 @default.
- W4385555322 hasPrimaryLocation W43855553221 @default.
- W4385555322 hasRelatedWork W1673187729 @default.
- W4385555322 hasRelatedWork W1849339974 @default.
- W4385555322 hasRelatedWork W1957770986 @default.
- W4385555322 hasRelatedWork W1985426726 @default.
- W4385555322 hasRelatedWork W2021999298 @default.
- W4385555322 hasRelatedWork W2112264559 @default.
- W4385555322 hasRelatedWork W2620124785 @default.
- W4385555322 hasRelatedWork W4237690111 @default.
- W4385555322 hasRelatedWork W4282919436 @default.
- W4385555322 hasRelatedWork W4318263723 @default.
- W4385555322 hasVolume "9" @default.
- W4385555322 isParatext "false" @default.
- W4385555322 isRetracted "false" @default.
- W4385555322 workType "article" @default.